Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients.
Lynoral: How To Order
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.
Vitamin B(12) in neurology and ageing; Clinical and genetic aspects.
Elan provides update post restructuring announcement of Tysabri collaboration
Cognitive assessment in MS.
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
Use and medicalization of marihuana in cancer patients.
Hypoxia Inducible Factor-1α in Astrocytes and/or Myeloid Cells Is Not Required for the Development of Autoimmune Demyelinating Disease(,.)
Multiple sclerosis: TNF receptor 1 gene variant could explain failure of TNF-blocking drugs in multiple sclerosis.
MS risk genes are transcriptionally regulated in CSF leukocytes at relapse.
A new therapeutic target for the treatment of multiple sclerosis.
[The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with Β-interferon 1a (avonex).]
The HLA region in multiple sclerosis.
The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis.
What is microglia neurotoxicity (Not)?
Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure.
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
What explains functioning from the perspective of people with multiple sclerosis?
Saffold Virus Type 3 (SAFV-3) Persists in HeLa Cells.
A review of current and emerging therapeutic strategies in multiple sclerosis.
Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population.
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series.
Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis.

Pages